The mortality rate for infective endocarditis remains high—too
high. In the preantibiotic era, death was inevitable for anyone unfortunate
enough to develop this disease. Penicillin changed this dismal picture. By
1951, based on more than 1000 cases of endocarditis compiled from several
reports, Hunter1 estimated that the overall
cure rate was about 70%. A half-century later, despite the advent of valve
replacement surgery and the development of many more antibiotics, the "global
cure rate" for infective endocarditis remains about the same. For example,
Hasbun et al2 recently reported a 6-month survival
rate of 74% among 513 patients with endocarditis in the United States. Similarly,
for 208 patients in England the cure rate at 6 months was 73%.3 Mortality
in a large tertiary-care hospital in the United States was about 35%.4 When more favorable rates have been reported, for
example from France by Hoen et al,5 the follow-up
period often was relatively short. The mortality for patients who have been
microbiologically "cured" continues to increase over years.6- 8 In
sum, it appears that little progress has been made.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 18
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.